| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 89 |
| 1 | PREDNISONE | 81 |
| 2 | METHOTREXATE SODIUM | 31 |
| 3 | METHYLPREDNISOLONE | 30 |
| 4 | ACETAMINOPHEN | 29 |
| 5 | DIPHENHYDRAMINE HYDROCHLORIDE | 28 |
| 6 | AZATHIOPRINE | 26 |
| 7 | ACETAMINOPHEN 500MG | 25 |
| 8 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 25 |
| 9 | PAIN RELIEVER | 25 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COCAINE HYDROCHLORIDE | 1 | 0.0026 |
| 1 | RITUXIMAB-ABBS | 6 | 0.0012 |
| 2 | HISTRELIN ACETATE | 1 | 0.0011 |
| 3 | PERINDOPRIL ERBUMINE | 6 | 0.0011 |
| 4 | MYCOPHENILIC ACID | 15 | 0.0007 |
| 5 | MINOCYCLINE HYDROCHLORIDE | 4 | 0.0007 |
| 6 | ALOGLIPTIN | 2 | 0.0006 |
| 7 | MYCOPHENOLIC ACID | 17 | 0.0005 |
| 8 | BRODALUMAB | 1 | 0.0005 |
| 9 | EPOPROSTENOL | 6 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD19-directed Cytolytic Antibody [EPC] | 12 | 0.0140 |
| 1 | Interleukin-5 Antagonist [EPC] | 7 | 0.0102 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 15 | 0.0007 |
| 3 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 97 | 0.0003 |
| 5 | Purine Antimetabolite [EPC] | 29 | 0.0003 |
| 6 | Thyroid Hormone Synthesis Inhibitor [EPC] | 2 | 0.0002 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 16 | 0.0002 |
| 8 | CD52-directed Cytolytic Antibody [EPC] | 3 | 0.0002 |
| 9 | Thymic Stromal Lymphopoietin Blocker [EPC] | 1 | 0.0001 |